PMC:7102583 / 0-195
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2 | 10-19 | Chemical | denotes | Melatonin | MESH:D008550 |
| 3 | 0-8 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 33 | 111-120 | Chemical | denotes | melatonin | MESH:D008550 |
| 38 | 143-151 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 10-19 | Body_part | denotes | Melatonin | http://purl.org/sig/ont/fma/fma74644 |
| T2 | 111-120 | Body_part | denotes | melatonin | http://purl.org/sig/ont/fma/fma74644 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 0-8 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 143-151 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 23-24 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 10-19 | Chemical | denotes | Melatonin | http://purl.obolibrary.org/obo/CHEBI_16796 |
| T2 | 35-43 | Chemical | denotes | adjuvant | http://purl.obolibrary.org/obo/CHEBI_60809 |
| T3 | 111-120 | Chemical | denotes | melatonin | http://purl.obolibrary.org/obo/CHEBI_16796 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 174-186 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-9 | Sentence | denotes | COVID-19: |
| T2 | 10-53 | Sentence | denotes | Melatonin as a potential adjuvant treatment |
| T3 | 55-63 | Sentence | denotes | Abstract |
| T4 | 64-187 | Sentence | denotes | This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. |